Table 2.
Univariate analysis of clinicopathological factors for overall survival.
Variable | n | Hazard ratio | 95% CI | P value |
---|---|---|---|---|
Age (years) | ||||
≤57 | 38 | 1 | 0.866–1.417 | 0.350 |
>57 | 28 | 0.728 | ||
Gender | ||||
Male | 57 | 1 | 0.912–3.749 | 0.088 |
Female | 19 | 1.849 | ||
Tumor size (cm) | ||||
≥5 | 42 | 1 | 0.264–1.116 | 0.097 |
<5 | 34 | 0.543 | ||
AFP (ng/mL) | ||||
≥400 | 36 | 1 | 0.387–1.506 | 0.436 |
<400 | 40 | 0.434 | ||
Metastasis | ||||
Yes | 47 | 1 | 1.396–5.647 | 0.004 ∗ |
No | 29 | 2.808 | ||
Tumor grade | ||||
G1 | 18 | 1 | 0.710–2.751 | 0.333 |
G2 | 24 | 1.398 | ||
G3 | 34 | |||
TNM stage | ||||
I-II | 40 | 1 | 1.626–6.946 | 0.001 ∗ |
III-IV | 36 | 3.360 | ||
Tumor recurrence | ||||
Yes | 46 | 1 | 0.171–0.657 | 0.007 ∗ |
No | 30 | 0.360 | ||
Microvascular invasion | ||||
Yes | 34 | 1 | 1.187–5.931 | 0.017 ∗ |
No | 42 | 2.654 | ||
miR-20b | ||||
High | 45 | 1 | 0.129–0.528 | 0.000 ∗ |
Low | 31 | 0.261 |
∗ P < 0.05.